EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Vitamin D Intake, Serum 25-Hydroxyvitamin-D (25(OH)D) Levels, and Cancer Risk: A Comprehensive Meta-Meta-Analysis Including Meta-Analyses of Randomized Controlled Trials and Observational Epidemiological Studies

Mehmet Emin Arayici iD, Yasemin Basbinar, Hulya Ellidokuz

Nutrients · 12.06.2023 · 15 (12) · 2722

DOI: 10.3390/nu15122722 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, online erschienen am 12.06.2023. Verfasst von Mehmet Emin Arayici und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Oncology, Institute of Health Sciences, Dokuz Eylul University, 15 July Medicine and Art Campus, Inciralti-Balcova 35340 İzm…. Hauptthemen laut MEDLINE: Vitamin D, Lung Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, Council of Higher Education, YOK (TURKEY).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is a well-established fact that inadequate Vitamin D (Vit-D) levels have negative effects on the development and progression of malignant diseases, particularly cancer. The purpose of this paper was to elucidate the effects of Vit-D intake and serum 25-hydroxyvitamin-D (25(OH)D) levels on cancer incidence and mortality, the current evidence in this field, and the biases of this evidence, using the meta-meta-analysis method. Meta-analyses focusing on Vit-D intake, serum 25(OH)D levels, and cancer risk/mortality were identified. A structured computer literature search was undertaken in PubMed/Medline, Web of Science (WoS), and Scopus electronic databases using predetermined keyword combinations. Primary and secondary meta-meta-analyses were carried out, combining odds ratios (ORs), risk ratios (RRs), and hazard ratios (HRs) for outcomes reported in selected meta-analyses. A total of 35 eligible meta-analyses (59 reports yielded from these studies) assessing the association between Vit-D and cancer incidence and/or mortality were included in this study. In the pooled analysis, higher Vit-D intake and serum 25(OH)D levels were associated with lower cancer risk (OR = 0.93, 95% confidence interval (CI): 0.90–0.96, p < 0.001; OR = 0.80, 95% CI: 0.72–0.89, p < 0.001, respectively) and cancer-related mortality (RR = 0.89, 95% CI: 0.86–0.93, p < 0.001; RR = 0.67, 95% CI: 0.58–0.78, p < 0.001, respectively). When meta-analyses whose primary reports included only randomized controlled trials were pooled, there was no significant association between Vit-D intake and cancer risk (OR = 0.99, 95% CI: 0.97–1.01, p = 0.320). In subgroup analysis, Vit-D consumption was associated with a significant decrease in colorectal and lung cancer incidence (OR = 0.89, 95% CI: 0.83–0.96, p = 0.002; OR = 0.88, 95% CI: 0.83–0.94, p < 0.001, respectively). Taken together, both Vit-D intake and higher 25(OH)D levels may provide remarkable benefits in terms of cancer incidence and mortality; however, careful evaluation according to cancer types is critically important and recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DLung NeoplasmsHumansRandomized Controlled Trials as TopicVitaminsCalcifediolEpidemiologic Studies

Stichwörter der Autor:innen

cancerincidencemeta-analysismortalityvitamin D

Substanzen

25-hydroxyvitamin DVitamin DVitaminsCalcifediol

Autor:innen und Institutionen

  • Department of Preventive Oncology, Institute of Health Sciences, Dokuz Eylul University, 15 July Medicine and Art Campus, Inciralti-Balcova 35340 İzmir, Türkiye.
  • Department of Translational Oncology, Institute of Oncology, Dokuz Eylul University, 35340 İzmir, Türkiye.
  • Department of Biostatistics and Medical Informatics, Faculty of Medicine, Dokuz Eylul University, 35340 İzmir, Türkiye.
  • Department of Preventive Oncology, Institute of Oncology, Dokuz Eylul University, 35340 İzmir, Türkiye.

ORCID-Profile: Mehmet Emin Arayici

Förderung

  • Scientific and Technological Research Council of Turkey
  • Council of Higher Education
  • YOK (TURKEY)
  • TUBITAK

Zitieren

APA

Arayici, M. E., Basbinar, Y., & Ellidokuz, H. (2023). Vitamin D Intake, Serum 25-Hydroxyvitamin-D (25(OH)D) Levels, and Cancer Risk: A Comprehensive Meta-Meta-Analysis Including Meta-Analyses of Randomized Controlled Trials and Observational Epidemiological Studies. Nutrients, 15(12), 2722. https://doi.org/10.3390/nu15122722

Vancouver

Arayici ME, Basbinar Y, Ellidokuz H. Vitamin D Intake, Serum 25-Hydroxyvitamin-D (25(OH)D) Levels, and Cancer Risk: A Comprehensive Meta-Meta-Analysis Including Meta-Analyses of Randomized Controlled Trials and Observational Epidemiological Studies. Nutrients. 2023;15(12):2722. doi:10.3390/nu15122722

BibTeX
@article{Arayici2023,
  author = {Arayici, Mehmet Emin and Basbinar, Yasemin and Ellidokuz, Hulya},
  title = {Vitamin D Intake, Serum 25-Hydroxyvitamin-D (25(OH)D) Levels, and Cancer Risk: A Comprehensive Meta-Meta-Analysis Including Meta-Analyses of Randomized Controlled Trials and Observational Epidemiological Studies},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {2722},
  doi = {10.3390/nu15122722}
}
Kostenlos starten →